Go
All Publishers
24/7 Market News
BTV Bulletin
BusinessWire
EasyPRwire
Evertise Digital
Financial News Media
GoBlockchain
IBN.ai
Prodigy Press Wire
KoreWire
Law Firm Newswire
MoneyShow Newswire
NewsDirect
NewsNetwork
Press Advantage
PRLog
PR Newswire
Press Services
Syndication Cloud
Erie Homeowners Urged to Schedule Furnace Checks Before Winter
Press Services
Today at 4:40pm UTC
Licensed Remodeler Expands Service to North County Coastal Cities
Press Services
Today at 4:40pm UTC
One Contractor Handles Full Home Remodels Across Houston
Press Services
Today at 4:40pm UTC
Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvalumab Plus Chemotherapy...
PR Newswire
Today at 3:31pm UTC
YogShri Healing: No. 1 Sound Healing Training & Research Institute in Rishikesh, India
EasyPR News
Today at 2:55pm UTC
Francoobla Music Announces the MAJESTATIS 7+7 Global Protocol: A Proposed Universal Mathematical Standard Against Musical Plagiarism and for...
EasyPR News
Today at 2:51pm UTC
JST Buyback & Burn Upgrade: GasFree Revenue and $20.34M Surplus Injected as JUST's Ecosystem Trio Solidifies JST Token Value
EasyPR News
Today at 2:47pm UTC
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of...
PR Newswire
Today at 1:45pm UTC
Roofing Contractors in San Antonio Serving Homes & Businesses
Press Services
Today at 1:05pm UTC
Studio 9 Salon Expands On-Location Bridal Services Across Metro Detroit
Press Services
Today at 12:50pm UTC
How Often Should Emergency Lighting Be Tested?
Syndication Cloud
Today at 12:45pm UTC
Livonia HVAC Company Urges Five Safety Checks Before the First Cold Snap
Press Services
Today at 12:35pm UTC
A Complete Guide to ANSUL Kitchen Fire Suppression Systems
Syndication Cloud
Today at 12:23pm UTC
Brown & Crouppen Warns of 43% Higher Halloween Pedestrian Risk
Press Services
Today at 12:20pm UTC
Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO
PR Newswire
Today at 11:01am UTC
The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and...
PR Newswire
Today at 10:37am UTC
2026 Investor Guide Targets High-Yield Abu Dhabi Off-Plan Deals
Press Services
Today at 10:15am UTC
Studio 9 Salon Reaches 3,300 Five-Star Reviews at 24 Years
Press Services
Today at 10:10am UTC
New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell...
PR Newswire
Today at 7:30am UTC
Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule
PR Newswire
Today at 7:30am UTC
<
1
2
3
4
5
6
...
19
20
>
Skip to content
Close menu
STREET
IQ
Top Stories
Top CEOs
Research
Press Releases
About Us